1 citations
,
November 2007 in “Neuro-chirurgie/Neurochirurgie” Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.
12 citations
,
January 1993 in “PubMed” July 2022 in “Dermatologic Therapy” March 2014 in “Annals of Internal Medicine” Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.
September 2006 in “Aktuelle Urologie” Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.
March 2026 in “Journal of Multidisciplinary Applied Natural Science” Cosmos caudatus extract is as effective as finasteride for treating benign prostatic hyperplasia without its side effects.
3 citations
,
May 2017 in “Bioorganic & medicinal chemistry letters” New compounds were made that are promising for prostate cancer therapy.
Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.
June 2021 in “European Urology” June 2010 in “Urology times” Finasteride causes fewer sexual side effects than dutasteride in men with BPH.
January 1975 in “NJEA Review” The drug showed promise in treating renal cell carcinoma with manageable side effects.
4 citations
,
October 2000 in “Contraception” The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.
3 citations
,
July 2009 in “Experimental and Clinical Endocrinology & Diabetes” Low-dose Buserelin effectively reduces hirsutism with minimal side effects.
January 2025 in “SSRN Electronic Journal” November 2018 in “Studies in Medical Sciences”
March 2015 in “The Journal of Urology” Finasteride reduces PSA levels by around 40-50% in BPH patients.
March 2008 in “European Urology Supplements” Finasteride and dutasteride can affect sexual function in BPH patients.
October 2021 in “European urology open science”
December 2019 in “Reactions Weekly” Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.
Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.
Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.
3 citations
,
March 2005 in “The Journal of urology/The journal of urology” Dutasteride may help shrink prostate cancer tumors.
January 2004 in “Drug Development and Industrial Pharmacy” GI197111X is best dissolved in Capmul MCM for trials.
July 2025 in “Journal of Investigative Dermatology”
September 2023 in “Forum Dermatologicum” Dutasteride injections can help treat hair loss in men and women.
November 2005 in “The Journal of Urology” Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.
August 2024 in “JAMA Dermatology” Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.
April 2023 in “Medicina Clínica (english Edition)” 3 citations
,
November 1998 in “PubMed”